Graham Capital Management’s Protagonist Therapeutics PTGX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $275K | Buy |
+4,979
| New | +$275K | ﹤0.01% | 986 |
|
|
2024
Q3 | – | Sell |
-7,574
| Closed | -$262K | – | 1265 |
|
|
2024
Q2 | $262K | Sell |
7,574
-10,638
| -58% | -$369K | 0.01% | 745 |
|
|
2024
Q1 | $527K | Buy |
+18,212
| New | +$527K | 0.01% | 591 |
|
|
2022
Q4 | – | Sell |
-53,443
| Closed | -$450K | – | 1280 |
|
|
2022
Q3 | $450K | Buy |
+53,443
| New | +$450K | 0.02% | 769 |
|